PCM1 and KRT15

  • Number of citations of the paper that reports this interaction (PMID 16189514)
  • 699

PCM1

KRT15

Gene Name pericentriolar material 1 keratin 15, type I
Image No pdb structure No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
  • Economic and political preferences ( 22566634)
Protein-Protein Interactions 17 interactors: ABI2 BBS4 CASK CCDC53 CEP131 CEP72 E2F4 EPS8 EXOC8 HAP1 ING5 KIAA0368 KRT15 KRT19 PCNT TTC8 YWHAQ 115 interactors: ABI2 ABI3 ABLIM1 AES ALS2CR11 AMOT AMOTL2 ANKRD36BP1 APC ARC ARFIP2 ATP5O BEX2 C10orf10 C1orf216 CALCOCO1 CCDC101 CCDC120 CCDC185 CCDC67 CCDC87 CCHCR1 CCNB1IP1 CCNC CEP57 COX5B CREB5 CYTH4 DGCR6L EPC1 EXOC8 FAM107A FAM110A GFAP GLYCTK HAUS1 HGS HMG20B HOXB6 IKBIP KANSL1 KIAA0408 KIAA1217 KIFC3 KLC3 KLC4 KRT18 KRT19 KRT20 KRT4 KRT5 KRT6A KRT6B KRT6C KRT71 KRT73 KRT77 KRT79 KRT8 KRT80 KRT81 KRT86 LDOC1 LMO2 LMO4 LNX1 MAD2L1BP MBD3 MCM10 MORN3 MOS NEFL NIF3L1 NOC4L NUDT18 NUP54 OIP5 PCM1 PIK3R2 PKN1 PPP1R18 PRPF31 PRPH PSMA1 PSMB1 PSMC5 RAD51D RCOR3 RHPN1 RIBC1 RIBC2 SIRPA SMARCD1 SMARCE1 SPG21 SSX2IP TCHP TEKT4 TIMM8A TMSB4X TRIM42 TSG101 TUBGCP4 TXLNA TXLNB TXNDC11 USHBP1 USP2 WAC ZC2HC1C ZFYVE26 ZGPAT ZNF417 ZNF576 ZNF638
Entrez ID 5108 3866
HPRD ID 02624 01009
Ensembl ID ENSG00000078674 ENSG00000171346
Uniprot IDs A2RUU9 E7ETA6 Q15154 A8MT21 B3KVF5 P19012
PDB IDs
Enriched GO Terms of Interacting Partners?
Tagcloud ?
9p24  allogeneic  asct  band  bcr  bridging  cytogenetic  discovery  encouraging  fusion  guide  hematologic  highlight  indispensable  jak1  jak2  myeloid  neoplasms  occurring  ongoing  options  p22  p24  q11  rearrangements  remission  ruxolitinib  termed  usually 
17beta  3a  additive  canonical  chemotherapeutic  chosen  combinatorial  communications  cooperation  cooperative  doxorubicin  epha2  ers  flt1  fuorouracil  gdnf  inpp5d  mcf7  microarrays  noncanonical  notch1  nutlin  responsiveness  searches  silenced  sox9  tlr5  transcriptome  vegfr 
Tagcloud (Difference) ?
9p24  allogeneic  asct  band  bcr  bridging  cytogenetic  discovery  encouraging  fusion  guide  hematologic  highlight  indispensable  jak1  jak2  myeloid  neoplasms  occurring  ongoing  options  p22  p24  q11  rearrangements  remission  ruxolitinib  termed  usually 
17beta  3a  additive  canonical  chemotherapeutic  chosen  combinatorial  communications  cooperation  cooperative  doxorubicin  epha2  ers  flt1  fuorouracil  gdnf  inpp5d  mcf7  microarrays  noncanonical  notch1  nutlin  responsiveness  searches  silenced  sox9  tlr5  transcriptome  vegfr 
Tagcloud (Intersection) ?